\
&
Contact us
Published on | 2 years ago
ProgrammesA total of 90 proposals were submitted to the 2023 research infrastructures calls with deadline 9 March 2023.
For the call HORIZON-INFRA-2023-DEV-01 Developing, consolidating and optimising the European research infrastructures landscape, maintaining global leadership (2023) a total of 47 proposals have been submitted. The breakdown per topics is the following:
For the call HORIZON-INFRA-2023-EOSC-01 Enabling an operational, open and FAIR EOSC ecosystem (2023) a total of 17 proposals have been submitted. The breakdown per topic is the following:
For the call HORIZON-INFRA-2023-SERV-01 Research infrastructure services to support health research, accelerate the green and digital transformation, and advance frontier knowledge (2023) 24 proposals have been submitted. The breakdown per topic is:
For the call HORIZON-INFRA-2023-TECH-01 Next generation of scientific instrumentation, tools, methods, and advanced digital solutions for RIs (2023) a total of 5 proposals have been submitted. The breakdown per topic is the following:
Evaluation results are expected to be communicated in July 2023.
Source: European Commission Funding and tender Portal
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.